首页> 美国卫生研究院文献>PLoS Clinical Trials >Optimal Deconvolution of Transcriptional Profiling Data Using Quadratic Programming with Application to Complex Clinical Blood Samples
【2h】

Optimal Deconvolution of Transcriptional Profiling Data Using Quadratic Programming with Application to Complex Clinical Blood Samples

机译:二次编程优化转录谱数据的反卷积及其在复杂临床血液样本中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Large-scale molecular profiling technologies have assisted the identification of disease biomarkers and facilitated the basic understanding of cellular processes. However, samples collected from human subjects in clinical trials possess a level of complexity, arising from multiple cell types, that can obfuscate the analysis of data derived from them. Failure to identify, quantify, and incorporate sources of heterogeneity into an analysis can have widespread and detrimental effects on subsequent statistical studies.We describe an approach that builds upon a linear latent variable model, in which expression levels from mixed cell populations are modeled as the weighted average of expression from different cell types. We solve these equations using quadratic programming, which efficiently identifies the globally optimal solution while preserving non-negativity of the fraction of the cells. We applied our method to various existing platforms to estimate proportions of different pure cell or tissue types and gene expression profilings of distinct phenotypes, with a focus on complex samples collected in clinical trials.We tested our methods on several well controlled benchmark data sets with known mixing fractions of pure cell or tissue types and mRNA expression profiling data from samples collected in a clinical trial. Accurate agreement between predicted and actual mixing fractions was observed. In addition, our method was able to predict mixing fractions for more than ten species of circulating cells and to provide accurate estimates for relatively rare cell types (<10% total population). Furthermore, accurate changes in leukocyte trafficking associated with Fingolomid (FTY720) treatment were identified that were consistent with previous results generated by both cell counts and flow cytometry. These data suggest that our method can solve one of the open questions regarding the analysis of complex transcriptional data: namely, how to identify the optimal mixing fractions in a given experiment.
机译:大规模的分子谱分析技术有助于疾病生物标志物的鉴定,并促进了对细胞过程的基本了解。但是,在临床试验中从人类受试者收集的样品具有一定程度的复杂性,这种复杂性是由多种细胞类型引起的,可能会混淆从它们衍生的数据的分析。未能识别,量化异质性来源并将其纳入分析可能会对随后的统计研究产生广泛而有害的影响。我们描述了一种基于线性潜在变量模型的方法,其中混合细胞群体的表达水平被建模为来自不同细胞类型的表达的加权平均值。我们使用二次编程来求解这些方程,二次编程可以有效地确定全局最优解,同时保留细胞分数的非负性。我们将方法应用到各种现有平台上,以估计不同纯细胞或组织类型的比例以及不同表型的基因表达谱,重点是在临床试验中收集的复杂样本。混合纯细胞或组织类型的分数以及来自临床试验中收集的样品的mRNA表达谱数据。观察到预测的和实际的混合分数之间的准确一致。此外,我们的方法能够预测十种以上循环细胞的混合比例,并能为相对稀有的细胞类型(<10%的总种群)提供准确的估计。此外,鉴定出与Fingolomid(FTY720)治疗相关的白细胞运输的准确变化,与先前通过细胞计数和流式细胞术得出的结果一致。这些数据表明我们的方法可以解决有关复杂转录数据分析的一个开放性问题:即如何在给定的实验中确定最佳的混合比例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号